- Homepage
- NanoKnife IRE Clinical Evidence
NanoKnife IRE Clinical Evidence
NanoKnife IRE is a cutting-edge technique which has shown very promising results in a series of clinical trials, particularly in its superior preservation of continence and erectile function as compared to Radical Prostatectomy.
In one study conducted in Australia between 2013 and 2018, 123 prostate cancer patients were treated with NanoKnife IRE, with a follow up of up to 6 years.
CLINICALLY PROVEN OUTCOMES
STUDY CONDUCTED IN AUSTRALIA BETWEEN 2013 AND 2018, 123 PROSTATE CANCER PATIENTS
In one study conducted in Australia between 2013 and 2018, 123 prostate cancer patients were treated with Nanoknife, with a follow up of up to 6 years.
Cancer control
97% were cured using NanoKnife IRE alone
15% had a recurrence within 5 years
3% needed to progress to full gland treatment within 3 years
Urinary continence
99% had no issue with urinary continence after the treatment.
Sexual potency*
76% reported no change in erectile function
request a callback
At The Focal Therapy Clinic we are passionate about prostate cancer sufferers knowing about all of their treatment options.
We know that settling on the right treatment is a big decision for you. If you would like to speak to one of our friendly and knowledgeable patient advocates about your diagnosis and our Focal Therapy treatment options then please do not hesitate to get in touch today.
All enquiries to The Focal Therapy Clinic are confidential, and we are delighted to offer our advice and support with no obligation.